Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma Biotech Investing
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Biotech Investing
Solarvest Launches World's First Organic DHA Omega-3 Fruit Gummy Drops for Children Biotech Investing
Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast Biotech Investing
Bristol Myers Squibb to Announce Results for Fourth Quarter 2020 on February 4, 2021 Biotech Investing
Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data Biotech Investing
Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Biotech Investing
